OBJECTIVE: To create and validate a simple, standardized version of the antisaccade (AS) task that requires no specialized equipment for use as a measure of executive function in multicenter clinical studies. METHODS: The bedside AS (BAS) task consisted of 40 pseudorandomized AS trials presented on a laptop computer. BAS performance was compared with AS performance measured using an infrared eye tracker in normal elders (NE) and individuals with mild cognitive impairment (MCI) or dementia (n = 33). The neuropsychological domain specificity of the BAS was then determined in a cohort of NE, MCI, and dementia (n = 103) at UCSF, and the BAS was validated as a measure of executive function in a 6-center cohort (n = 397) of normal adults and patients with a variety of brain diseases. RESULTS: Performance on the BAS and laboratory AS task was strongly correlated and BAS performance was most strongly associated with neuropsychological measures of executive function. Even after controlling for disease severity and processing speed, BAS performance was associated with multiple assessments of executive function, most strongly the informant-based Frontal Systems Behavior Scale. CONCLUSIONS: The BAS is a simple, valid measure of executive function in aging and neurologic disease.
OBJECTIVE: To create and validate a simple, standardized version of the antisaccade (AS) task that requires no specialized equipment for use as a measure of executive function in multicenter clinical studies. METHODS: The bedside AS (BAS) task consisted of 40 pseudorandomized AS trials presented on a laptop computer. BAS performance was compared with AS performance measured using an infrared eye tracker in normal elders (NE) and individuals with mild cognitive impairment (MCI) or dementia (n = 33). The neuropsychological domain specificity of the BAS was then determined in a cohort of NE, MCI, and dementia (n = 103) at UCSF, and the BAS was validated as a measure of executive function in a 6-center cohort (n = 397) of normal adults and patients with a variety of brain diseases. RESULTS: Performance on the BAS and laboratory AS task was strongly correlated and BAS performance was most strongly associated with neuropsychological measures of executive function. Even after controlling for disease severity and processing speed, BAS performance was associated with multiple assessments of executive function, most strongly the informant-based Frontal Systems Behavior Scale. CONCLUSIONS: The BAS is a simple, valid measure of executive function in aging and neurologic disease.
Authors: Allen D Radant; Dorcas J Dobie; Monica E Calkins; Ann Olincy; David L Braff; Kristin S Cadenhead; Robert Freedman; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Gregory A Light; Sean P Meichle; Jim Mintz; Keith H Nuechterlein; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Ming T Tsuang; Bruce I Turetsky; Debby W Tsuang Journal: Schizophr Res Date: 2006-10-03 Impact factor: 4.939
Authors: Joel H Kramer; Jennifer Jurik; Sharon J Sha; Kate P Rankin; Howard J Rosen; Julene K Johnson; Bruce L Miller Journal: Cogn Behav Neurol Date: 2003-12 Impact factor: 1.600
Authors: Sarah J Tabrizi; Douglas R Langbehn; Blair R Leavitt; Raymund Ac Roos; Alexandra Durr; David Craufurd; Christopher Kennard; Stephen L Hicks; Nick C Fox; Rachael I Scahill; Beth Borowsky; Allan J Tobin; H Diana Rosas; Hans Johnson; Ralf Reilmann; Bernhard Landwehrmeyer; Julie C Stout Journal: Lancet Neurol Date: 2009-07-29 Impact factor: 44.182
Authors: Siobhan Garbutt; Alisa Matlin; Joanna Hellmuth; Ana K Schenk; Julene K Johnson; Howard Rosen; David Dean; Joel Kramer; John Neuhaus; Bruce L Miller; Stephen G Lisberger; Adam L Boxer Journal: Brain Date: 2008-03-24 Impact factor: 13.501
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Kirk R Daffner; Seth A Gale; A M Barrett; Bradley F Boeve; Anjan Chatterjee; H Branch Coslett; Mark D'Esposito; Glen R Finney; Darren R Gitelman; John J Hart; Alan J Lerner; Kimford J Meador; Alison C Pietras; Kytja S Voeller; Daniel I Kaufer Journal: Neurology Date: 2015-07-10 Impact factor: 9.910
Authors: Judy Pa; Shubir Dutt; Jacob B Mirsky; Hilary W Heuer; Paul Keselman; Erwin Kong; Andrew Trujillo; Adam Gazzaley; Joel H Kramer; William W Seeley; Bruce L Miller; Adam L Boxer Journal: Neuroimage Date: 2014-03-24 Impact factor: 6.556
Authors: Uma Vaidyanathan; Stephen M Malone; Jennifer M Donnelly; Micah A Hammer; Michael B Miller; Matt McGue; William G Iacono Journal: Psychophysiology Date: 2014-12 Impact factor: 4.016
Authors: Adam L Boxer; Michael Gold; Edward Huey; William T Hu; Howard Rosen; Joel Kramer; Fen-Biao Gao; Edward A Burton; Tiffany Chow; Aimee Kao; Blair R Leavitt; Bruce Lamb; Megan Grether; David Knopman; Nigel J Cairns; Ian R Mackenzie; Laura Mitic; Erik D Roberson; Daniel Van Kammen; Marc Cantillon; Kathleen Zahs; George Jackson; Stephen Salloway; John Morris; Gary Tong; Howard Feldman; Howard Fillit; Susan Dickinson; Zaven S Khachaturian; Margaret Sutherland; Susan Abushakra; Joseph Lewcock; Robert Farese; Robert O Kenet; Frank Laferla; Steve Perrin; Steve Whitaker; Lawrence Honig; Marsel M Mesulam; Brad Boeve; Murray Grossman; Bruce L Miller; Jeffrey L Cummings Journal: Alzheimers Dement Date: 2012-10-10 Impact factor: 21.566
Authors: Joel H Kramer; Dan Mungas; Katherine L Possin; Katherine P Rankin; Adam L Boxer; Howard J Rosen; Alan Bostrom; Lena Sinha; Ashley Berhel; Mary Widmeyer Journal: J Int Neuropsychol Soc Date: 2013-10-08 Impact factor: 2.892
Authors: Jane E Schreiber; Katherine L Possin; Jonathan M Girard; Celiane Rey-Casserly Journal: J Int Neuropsychol Soc Date: 2013-10-08 Impact factor: 2.892
Authors: Hilary W Heuer; Jacob B Mirsky; Erwin L Kong; Bradford C Dickerson; Bruce L Miller; Joel H Kramer; Adam L Boxer Journal: Neurology Date: 2013-08-28 Impact factor: 9.910